Tags: Drug.

Gantenerumab is a monoclonal antibody for the treatment of Alzheimer’s disease. A phase I clinical trial has been conducted in 2006/07.Gantenerumab is currently being evaluated in a prodromal Alzheimer’s Disease population in the Scarlet Road study a global phase II study of approximately 360 subjects in 100 centers in 15 countries.

ATC prefix
none
CAS number
89957-37-9
FDA UNII code
4DF060P933

Loading...

This page contains content from the copyrighted Wikipedia article "Gantenerumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.